NUCLIDIUM AG, a clinical-stage radiopharmaceutical company developing a proprietary copper-based theranostic platform, today announced that the company’s abstract featuring first clinical data from ...

As AI tools become more common, lawyers must strengthen their online presence—through media mentions, accurate profiles, and ...